Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-003233
Filing Date
2025-03-26
Accepted
2025-03-26 10:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27708
2 filename2.txt TEXT-EXTRACT 1184
  Complete submission text file 0000000000-25-003233.txt   40121
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filed for) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-286005
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)